|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 104, 659-665, Copyright © 1992 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
T Yeh Jr, JM Parmar, IM Rebeyka, GK Lofland, EL Allen, RJ Dignan, CM Dyke and AS Wechsler
The marked edema observed in neonatal cardiopulmonary bypass is thought to
result from pathologic increases in capillary permeability. Pentafraction
is a subfraction of hydroxyethyl starch that is thought to be of
appropriate size and shape to be retained by leaking capillaries and seal
endothelial gaps in capillary basement membranes. To test the hypothesis
that pentafraction would reduce edema in neonatal cardiopulmonary bypass,
we established a model of edema formation in neonatal bypass in which
neonatal piglets underwent 2 hours of normothermic cardiopulmonary bypass
with crystalloid prime and no myocardial ischemia. Before initiation of
bypass, experimental animals (n = 11) received intravenous pentafraction, 3
gm/kg. Control animals (n = 10) received an equivalent volume of saline.
Hemodynamic parameters, animal weight, fluid redistribution, and percent
tissue water of individual organs were assessed during and after bypass.
Pentafraction treatment resulted in significant differences in (1) lowered
percent body weight gain from baseline (11% versus 48%), (2) lowered volume
requirement to maintain venous reservoir during cardiopulmonary bypass (148
ml/kg versus 581 ml/kg), (3) less fluid loss from the peritoneum (11 ml/kg
versus 115 ml/kg), and (4) lowered percent tissue water of kidney,
pancreas, stomach, jejunum, colon, and skeletal muscle (p less than 0.05 by
unpaired t test). Pentafraction had no effect on hemodynamic parameters
during bypass nor in percent tissue water of heart, lung, liver, spleen,
skin, or brain. In summary, pentafraction lessened weight gain and fluid
requirements during cardiopulmonary bypass, favorably influencing the
percent tissue water of certain organs. If pentafraction functions as
proposed, it may have wide applicability not only in cardiopulmonary bypass
(or extracorporeal membrane oxygenation) but also in other clinical
scenarios with altered capillary permeability.
ARTICLES
Limiting edema in neonatal cardiopulmonary bypass with narrow-range molecular weight hydroxyethyl starch
Medical College of Virginia/Virginia Commonwealth University, Richmond 23298.
This article has been cited by other articles:
![]() |
E Hirleman and D. Larson Cardiopulmonary bypass and edema: physiology and pathophysiology Perfusion, November 1, 2008; 23(6): 311 - 322. [Abstract] [PDF] |
||||
![]() |
M. Farstad, V. L. Kvalheim, and P. Husby Cold-induced fluid extravasation during cardiopulmonary bypass in piglets can be counteracted by use of iso-oncotic prime J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 287 - 294. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lang, J. Boldt, S. Suttner, and G. Haisch Colloids Versus Crystalloids and Tissue Oxygen Tension in Patients Undergoing Major Abdominal Surgery Anesth. Analg., August 1, 2001; 93(2): 405 - 409. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Simonardottir, B. Torfason, and J. Magnusson Is compartment pressure related to plasma colloid osmotic pressure, in patients during and after cardiac surgery? Perfusion, March 1, 2001; 16(2): 137 - 145. [Abstract] [PDF] |
||||
![]() |
P. W. Morgan and J. C. Berridge Giving long-persistent starch as volume replacement can cause pruritus after cardiac surgery Br. J. Anaesth., November 1, 2000; 85(5): 696 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. NICHANI Albumin: saint or sinner? Arch. Dis. Child., August 1, 1999; 81(2): 189c - 189. [Full Text] |
||||
![]() |
M. J Elliott Recent advances in paediatric cardiopulmonary bypass Perfusion, July 1, 1999; 14(4): 237 - 246. [PDF] |
||||
![]() |
P. Gosling Prevention of post-traumatic clinical capillary leak syndrome Trauma, April 1, 1999; 1(2): 91 - 103. [Abstract] [PDF] |
||||
![]() |
H. Niwa, M. Nara, T. Kimura, Y. Chiba, A. Ihaya, K. Morioka, T. Uesaka, T. Tsuda, and R. Muraoka Prolongation of total permissible circulatory arrest duration by deep hypothermic intermittent circulatory arrest J. Thorac. Cardiovasc. Surg., July 1, 1998; 116(1): 163 - 167. [Abstract] [Full Text] |
||||
![]() |
T. Shin'oka, D. Shum-Tim, P. C. Laussen, S. M. Zinkovsky, H. G. W. Lidov, A. d. Plessis, and R. A. Jonas Effects of Oncotic Pressure and Hematocrit on Outcome After Hypothermic Circulatory Arrest Ann. Thorac. Surg., January 1, 1998; 65(1): 155 - 164. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |